FMP
NASDAQ
0.704 USD
0.0903 (12.82%)
Dr. Brian M. Strem Ph.D.
Healthcare
Biotechnology
https://www.kiorapharma.com
NASDAQ
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid arthritis, as well as for treating non-infectious posterior uveitis; and KIO-201, an eye drop, which is in Phase 3 clinical trial for treating patient...
0001372514
US49721T3095
49721T101
1371 East 2100 South
781 788 8869
US
12
Feb 13, 2015
0001372514
NASDAQ
Biotechnology
Healthcare
49721T101
US49721T3095
US
0.7
-0.29
1.66M
18.49M
-
0.462-5.25
0.48
-
-
-
-
0.9
-
https://www.kiorapharma.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.